Greatbatch
-
Greatbatch receives FDA approval for spinal cord stimulation system
Greatbatch Inc. recently announced it has received FDA approval for its Algovita Spinal Cord Stimulation System to treat chronic intractable…
Read More » -
Financial
Greatbatch Receives Average Rating of “Buy” from Brokerages (NYSE:GB)
Greatbatch (NYSE:GB) has been assigned a consensus recommendation of “Buy” from the six analysts that are presently covering the stock, Market Beat.com reports.…
Read More » -
Financial
Greatbatch (GB) – Analysts’ Recent Ratings Change
By Maddie Sorenson Greatbatch (NYSE: GB) has recently received a number of price target changes and ratings updates: 8/29/2015 – Greatbatch had…
Read More » -
Financial
Greatbatch’s(GB) CEO Thomas Hookon Q1 2015 Results – Earnings Call Transcript
Operator Welcome, everyone, to the first quarter 2015 Greatbatch Incorporated conference call. Before we begin, I would like to read…
Read More » -
Greatbatch, Inc. Reports 2009 Third Quarter Results
CLARENCE, N.Y.–(BUSINESS WIRE)–Greatbatch, Inc. (NYSE:GB – News), today announced results for its third quarter ended October 2, 2009: * CRM/Neuromodulation…
Read More »